Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting
Abstract
Authors
N Kragh E Ye B Hunt WJ Valentine
N Kragh E Ye B Hunt WJ Valentine
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now